Back to results
WithdrawnPhase 3

REVERSE-Long COVID-19 With Baricitinib Study

NCT05858515

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of California San Francisco

San Francisco, California, United States

+5 additional locations

View on ClinicalTrials.gov
REVERSE-Long COVID-19 With Baricitinib Study — TrialFind